Article
Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug…
medRxiv · 2024 · Shahrouzi, P.; Azimzade, Y.; Brankiewicz, W.; Bhatia, S.; Kunke, D.; Richard, D.; Tekpli, X.; Kristensen, V. N.; Duijf, P. H. G.
Key facts
| Title | Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response |
|---|---|
| First author | Shahrouzi, P.; Azimzade, Y.; Brankiewicz, W.; Bhatia, S.; Kunke, D.; Richard, D.; Tekpli, X.; Kristensen, V. N.; Duijf, P. H. G. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.06.18.599481 |
| Devices mentioned | BK110039, DEN000008, K022086, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 4 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 7 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1